Having shown that ADAM12 and CYP1B1 depletion in CAAs drastically attenuates RCC cell growth and migration in vitro, we evaluated the role of these two genes in the tumor microenvironment for the oncogenic potential of RCC cells in xenografts, in vivo, n = 8. This evidence concerns the gene ADAM12 and renal cell carcinoma.